Novonesis Statistics

Total Valuation

Novonesis has a market cap or net worth of 30.30 billion. The enterprise value is 31.92 billion.

Market Cap	30.30B
Enterprise Value	31.92B

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	Apr 4, 2025

Share Statistics

Current Share Class	412.17M
Shares Outstanding	n/a
Shares Change (YoY)	-8.56%
Shares Change (QoQ)	+68.44%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	346.64M

Valuation Ratios

The trailing PE ratio is 61.15 and the forward PE ratio is 28.73.

PE Ratio	61.15
Forward PE	28.73
PS Ratio	6.91
PB Ratio	2.50
P/TBV Ratio	20.71
P/FCF Ratio	45.84
P/OCF Ratio	29.52
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.38, with an EV/FCF ratio of 48.28.

EV / Earnings	64.40
EV / Sales	7.07
EV / EBITDA	24.38
EV / EBIT	31.29
EV / FCF	48.28

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.15.

Current Ratio	1.66
Quick Ratio	1.03
Debt / Equity	0.15
Debt / EBITDA	1.44
Debt / FCF	2.78
Interest Coverage	11.41

Financial Efficiency

Return on equity (ROE) is 6.97% and return on invested capital (ROIC) is 7.25%.

Return on Equity (ROE)	6.97%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	7.25%
Return on Capital Employed (ROCE)	6.64%
Revenue Per Employee	414,444
Profits Per Employee	46,831
Employee Count	10,582
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +15.82% in the last 52 weeks. The beta is 0.55, so Novonesis's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	+15.82%
50-Day Moving Average	60.11
200-Day Moving Average	61.02
Relative Strength Index (RSI)	64.34
Average Volume (20 Days)	1,855

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novonesis had revenue of 4.39 billion and earned 495.57 million in profits. Earnings per share was 1.71.

Revenue	4.39B
Gross Profit	2.31B
Operating Income	996.22M
Pretax Income	664.50M
Net Income	495.57M
EBITDA	1.28B
EBIT	996.22M
Earnings Per Share (EPS)	1.71

Full Income Statement

Balance Sheet

The company has 269.67 million in cash and 1.84 billion in debt, giving a net cash position of -1.57 billion.

Cash & Cash Equivalents	269.67M
Total Debt	1.84B
Net Cash	-1.57B
Net Cash Per Share	n/a
Equity (Book Value)	12.14B
Book Value Per Share	26.04
Working Capital	838.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.03 billion and capital expenditures -365.54 million, giving a free cash flow of 661.05 million.

Operating Cash Flow	1.03B
Capital Expenditures	-365.54M
Free Cash Flow	661.05M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 52.73%, with operating and profit margins of 22.72% and 11.30%.

Gross Margin	52.73%
Operating Margin	22.72%
Pretax Margin	15.15%
Profit Margin	11.30%
EBITDA Margin	29.12%
EBIT Margin	22.72%
FCF Margin	15.07%

Dividends & Yields

This stock pays an annual dividend of 0.92, which amounts to a dividend yield of 1.37%.

Dividend Per Share	0.92
Dividend Yield	1.37%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	54.46%
Buyback Yield	8.56%
Shareholder Yield	9.93%
Earnings Yield	1.64%
FCF Yield	2.18%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novonesis has an Altman Z-Score of 5.71.

Altman Z-Score	5.71
Piotroski F-Score	n/a